Eleven Tx
2 known investors
Eleven Therapeutics develops mRNA therapeutics by combining synthetic chemistry with AI, using massively-parallel processes to map RNA chemical space and determine structure-activity relationships. The platform optimizes RNA molecules for safety, efficiency, and duration of effect.
Investors · 2
Frequently asked questions
- What does Eleven Tx do?
- Eleven Therapeutics develops mRNA therapeutics by combining synthetic chemistry with AI, using massively-parallel processes to map RNA chemical space and determine structure-activity relationships. The platform optimizes RNA molecules for safety, efficiency, and duration of effect.
- Who are Eleven Tx's investors?
- Eleven Tx's investors include Entrée Capital, Kindred Capital.